Felix Scholz

Felix Scholz is an accomplished scientist and business leader with extensive experience in immunology and research. Currently serving as CEO and President of Infectolab Americas since June 2018, Felix also founded Novabiota in August 2022. Previously, Felix held the position of Head of Immunology R&D at Pharmasan Labs Inc. from September 2014 to May 2018, focusing on the development of immunoassays. Additional roles include working as an immunologist at Beckman Coulter and various research fellowships at esteemed institutions such as the University of Minnesota, Mayo Clinic, and Christian-Albrechts-Universität zu Kiel. Felix holds a Ph.D. in Cellular and Molecular Biology from Kiel University and a Biology Diplom from The Philipp University of Marburg.